Keyphrases
Tissue Plasminogen Activator (t-PA)
100%
Ischemic Stroke
80%
Emergency Medical Services
80%
Blood Collection
80%
Door-to-needle Time
66%
Career Pathways
40%
Blood Hemostasis
40%
Coagulation-fibrinolysis
40%
Acute Ischemic Stroke
40%
Mentoring Program
40%
Influenza Vaccine
40%
Hyperglycemia
40%
Pharmacy
40%
Postgraduate Training
40%
Elective Course
40%
Patients with Diabetes
40%
Innovative Approach
40%
Blood Coagulation
40%
Coagulation Hemostasis
40%
Mentorship
40%
Revaccination
34%
Training Workshop
26%
Matching Rate
26%
Pharmacy Residency Match
26%
National Rate
26%
College of Pharmacy
26%
Andexanet Alfa
20%
Tranexamic Acid
20%
Aminocaproic Acid
20%
Idarucizumab
20%
Warfarin
20%
Systemic Review
20%
Meta-analysis
20%
Low Molecular Weight Heparin
20%
Direct Oral Anticoagulants
20%
Blood Glucose
17%
Fibrinolytic Therapy
13%
Ischemic Stroke Diagnosis
13%
Emergency Personnel
13%
Level II Trauma Centers
13%
Patient Arrivals
13%
Alteplase
13%
Comprehensive Stroke Center
13%
Service Groups
13%
Usual Care
13%
Chart Review
13%
Electronic Medical Records
13%
Adult Patients
13%
Time-to-treatment
13%
United States
13%
Nursing and Health Professions
Blood Sampling
80%
Tissue Plasminogen Activator
80%
Brain Ischemia
80%
Triage
80%
Influenza Vaccine
40%
Patient with Diabetes
40%
Vaccination Policy
40%
Hyperglycemia
40%
Fibrinolytic Agent
20%
Glucose Blood Level
13%
Vaccine Efficacy
13%
Care Group
10%
Alteplase
10%
Community Hospital
10%
Cohort Analysis
10%
Time to Treatment
10%
Electronic Medical Record
10%
Medicine and Dentistry
Blood Sampling
80%
Triage
80%
Brain Ischemia
80%
Tissue Plasminogen Activator
80%
Hyperglycemia
40%
Patient with Diabetes
40%
Influenza Vaccine
40%
Apoplexy
20%
Blood Glucose
17%
Retrospective Cohort Study
10%
Electronic Patient Record
10%
Alteplase
10%
Care Group
10%
Time to Treatment
10%
Prospective Cohort Study
5%
Counseling
5%
Diabetes Mellitus
5%
Single Drug Dose
5%
Adverse Event
5%
Hemoglobin A1c
5%
Drug Therapy
5%
